ACW 3.70% 2.6¢ actinogen medical limited

Well-timed XanaHES study saves the day, page-2

  1. 1,141 Posts.
    lightbulb Created with Sketch. 208
    Very interesting and encouraging. The Edison report states that until further R&D is done, the valuation is 12 cents per share. It also says that this is a conservative estimate. Good times ahead.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.